Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
Lung cancer is the leading cause of cancer deaths, with an overall survival of 15% at five years. Biomarkers that can sensitively and specifically detect lung cancer at early stage are crucial for improving this poor survival rate. Sputum has been the target for the discovery of non-invasive biomark...
Main Authors: | William N. Rom, Kam-Meng Tchou-Wong, Connie E. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/3/2975/ |
Similar Items
-
Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
by: Ning Li, et al.
Published: (2021-02-01) -
Evaluation of lung flute in sputum samples for molecular analysis of lung cancer
by: Nigar Anjuman, et al.
Published: (2013-12-01) -
Microbiota Biomarkers for Lung Cancer
by: Qixin Leng, et al.
Published: (2021-02-01) -
Role and Significance of Bioactive Substances in Sputum
in the Diagnosis of Lung Cancer
by: Yuming JIN, et al.
Published: (2021-12-01) -
An evaluation of methods of inducing sputum production in patient with suspected lung cancer
by: Maha Shakir Hassan
Published: (2007-01-01)